Rchr
J-GLOBAL ID:201201026868621950   Update date: Apr. 17, 2024

ICHIRO KAWAHATA

カワハタ イチロウ | ICHIRO KAWAHATA
Affiliation and department:
Job title: Associate Professor
Research field  (3): Pharmacology ,  Pharmaceuticals - health and biochemistry ,  Neuroscience - general
Research keywords  (18): Lewy Body Dementia ,  diagnostic technology ,  biomarker ,  fatty acid-binding protein ,  dopamine receptor ,  FABP3 ,  α-synuclein ,  Dystonia ,  aging ,  cranial nerve disease ,  catecholamine ,  dopamine ,  V-1/CP complex ,  sinensetin ,  nobiletin ,  Alzheimer's disease ,  tyrosine hydroxylase ,  Parkinson's disease
Research theme for competitive and other funds  (18):
  • 2022 - 2025 Novel Drug Discovery and Therapeutics Development for Lewy Body Disease Targeting Fatty Acid-Binding Proteins
  • 2022 - 2025 パーキンソン病の新規治療戦略と超早期予測技術の開発
  • 2022 - 2025 パーキンソン病認知症およびレビー小体型認知症による神経変性の根本治療薬開発
  • 2021 - 2024 ドパミン受容体モデュレーターを介したニコチン依存形成と治療薬開発
  • 2020 - 2023 パーキンソン病の新規治療戦略と超早期予測技術の開発
Show all
Papers (92):
  • Ichiro Kawahata, David I. Finkelstein, Kohji Fukunaga. Dopamine D1-D5 Receptors in Brain Nuclei: Implications for Health and Disease. Receptors. 2024
  • Tomoki Sekimori, Kohji Fukunaga, Hideki Oizumi, Toru Baba, Tomoko Totsune, Atsushi Takeda, Takuya Sasaki, Ichiro Kawahata. FABP2 is Involved in Intestinal α-Synuclein Pathologies. Journal of Integrative Neuroscience. 2024. 23. 2. 44-44
  • Ichiro Kawahata, Atsushi Takeda, Kohji Fukunaga. Development of early prediction and discriminating techniques for Lewy body diseases. Folia Pharmacologica Japonica. 2024. 159. 1. 2-5
  • Ichiro Kawahata, Kohji Fukunaga. Pathogenic Impact of Fatty Acid-Binding Proteins in Parkinson’s Disease-Potential Biomarkers and Therapeutic Targets. International Journal of Molecular Sciences. 2023. 24. 23. 17037-17037
  • Ichiro Kawahata, Tomoki Sekimori, Hideki Oizumi, Atsushi Takeda, Kohji Fukunaga. Using Fatty Acid-Binding Proteins as Potential Biomarkers to Discriminate between Parkinson’s Disease and Dementia with Lewy Bodies: Exploration of a Novel Technique. International Journal of Molecular Sciences. 2023. 24. 17. 13267-13267
more...
MISC (83):
  • Ichiro Kawahata, Atsushi Takeda, Kohji Fukunaga. Development of early prediction and discriminating techniques for Lewy body diseases. Folia Pharmacologica Japonica. 2024. 159. 1. 2-5
  • Ichiro Kawahata, Masahiro Nagai. Preface. Folia Pharmacologica Japonica. 2024. 159. 1. 1-1
  • 福永浩司, 西哲郎, 福永康太, 川畑伊知郎. 人間ドックで有効な認知症リスクの血液中バイオマーカーの開発. 人間ドック. 2023. 38. 2
  • 川畑 伊知郎, 福永 浩司. シヌクレイノパチーを予防可能な新規ペプチド治療薬の創製-Development of Novel Peptide Therapeutics to Prevent α-synucleinopathies-特集 注目される創薬研究と新技術開発. 化學工業. 2023. 74. 1. 41-46
  • 福永 浩司, 川畑 伊知郎. 認知症のリスクを検知する血液中バイオマーカーの開発. 人間ドック. 2022. 37. 2. 375-375
more...
Patents (7):
  • FABP3/FABP4に親和性の高いシヌクレイノパチー治療薬
  • Peptides used to prevent or treat synucleinopathy
  • Biomarker for dementia diagnosis
  • 医薬組成物
  • ローヤルゼリー分画の製造方法
more...
Books (4):
  • シヌクレイノパチーを予防可能な新規ペプチド治療薬の創製
    化学工業 2022
  • Endocytosis of dopamine receptor: signaling in brain
    Elsevier 2022
  • Development of Novel Medium-molecular Therapeutics for Lewy Body Disease
    2022
  • 医療・診断をめざす先端バイオテクノロジー
    工学図書 2009 ISBN:9784769204909
Lectures and oral presentations  (84):
  • これからの瀬川病~未来を拓く~
    (瀬川小児病院創立120周年・瀬川病発見50周年 記念講演会 2023)
  • Uncovering the Role of Fatty Acid-Binding Proteins in Mitochondrial Dysfunction: A Potential Therapy for Dementia and Cerebrovascular Injury
    (12th World Congress of Microcirculation 2023)
  • Fatty acid-binding proteins 3 and 5 mediate the mitochondrial damage in brain ischemia
    (Satellite Symposium in 12th World Congress of Microcirculation 2023)
  • Frontiers in neuronal homeostasis in aging and disease and its therapeutic applications
    (The 46th Annual Meeting of the Japan Neuroscience Society 2023)
  • The novel therapeutic ligand targeting fatty acid-binding protein 3 prevents α-synuclein accumulation and cognitive-motor impairments in Lewy body disease-model mice
    (17th International Conference on Alzheimer’s & Parkinson’s Diseases 2023)
more...
Education (1):
  • 2006 - 2009 Tokyo Institute of Technology Department of Bioscience and Biotechnology Molecular Life Science
Professional career (2):
  • Ph.D. (Science) (Tokyo Institute of Technology)
  • Ph.D. (Pharmaceutical Science) (Tohoku University)
Committee career (4):
  • 2021 - 現在 日本薬理学会 次世代の会 運営委員
  • 2019/04 - 現在 The Japanese Pharmacological Society Councilor
  • 2019 - 現在 日本薬学会 薬理系薬学部会 若手世話人
  • 2019 - 現在 日本薬理学会 評議員
Awards (11):
  • 2023/09 - 東北大学 東北大学大学院薬学研究科長賞
  • 2022/07 - 東北大学 東北大学大学院薬学研究科長賞
  • 2021/12 - JSNP Excellent Presentation Award for AsCNP
  • 2021/03 - The Japanese Pharmacological Society Young Researcher's Award
  • 2020/12 - International Conference on Protein Phosphatase The Young Investigator Award
Show all
Association Membership(s) (10):
日本生薬学会 ,  Society for Neuroscience ,  日本薬学会 ,  Japanese Pharmacological Society ,  Japanese Biochemical Society ,  Japan Neuroscience Society ,  日本神経学会 ,  日本神経化学会 ,  THE JAPANESE SOCIETY OF NEUROPSYCHOPHARMACOLOGY ,  JAPAN BRAIN SCIENCE SOCIETY
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page